New therapeutic targets for osteoporosis

P Anagnostis, NK Gkekas, M Potoupnis, E Kenanidis… - Maturitas, 2019 - Elsevier
New anti-osteoporotic agents have been developed, potentially enriching the therapeutic
armamentarium. Currently available osteoanabolic therapies are the parathyroid hormone …
被引用次数：72 相关文章

New therapeutic targets for osteoporosis

P Anagnostis, NK Gkekas, M Potoupnis, E Kenanidis… - Maturitas, 2019 - maturitas.org
New anti-osteoporotic agents have been developed, potentially enriching the therapeutic
armamentarium. Currently available osteoanabolic therapies are the parathyroid hormone …
[PDF] potoupnis.gr

[PDF][PDF] New therapeutic targets for osteoporosis

P Anagnostis, NK Gkekas, M Potoupnis, E Kenanidis… - 2018 - potoupnis.gr
New anti-osteoporotic agents have been developed, potentially enriching the therapeutic
armamentarium. Currently available osteoanabolic therapies are the parathyroid hormone …

New therapeutic targets for osteoporosis.

P Anagnostis, NK Gkekas, M Potoupnis, E Kenanidis… - Maturitas, 2018 - europepmc.org
New anti-osteoporotic agents have been developed, potentially enriching the therapeutic
armamentarium. Currently available osteoanabolic therapies are the parathyroid hormone …

New therapeutic targets for osteoporosis

P Anagnostis, NK Gkekas, M Potoupnis… - …, 2019 - pubmed.ncbi.nlm.nih.gov
New anti-osteoporotic agents have been developed, potentially enriching the therapeutic
armamentarium. Currently available osteoanabolic therapies are the parathyroid hormone …